|
Post by Logan on Jan 20, 2016 19:46:13 GMT -6
ALBANY — Children and young adults with epilepsy may qualify for investigational studies of cannabidiol, an ingredient in marijuana, slated to begin soon in New York, the state Health Department announced Wednesday. Vireo Health of New York Chief Cultivator Chuck Schmitt examines a marijuana plant earlier this month. (John Carl D'Annibale / Times Union) Patients aged 1 to 21 with treatment-resistant epilepsy may qualify for the study, to be held at five locations — three in New York City, one in Rochester and one in Buffalo. “These studies will give patients in New York State who are not responding to conventional anti-epileptic therapy access to a drug that has shown promise in previous expanded access studies,” said state Health Commissioner Howard Zucker. Initial enrollment of patients is expected to begin in the next few months. Children with epilepsy already qualify to get medical marijuana under the state’s nascent program. But the specific product being studied, Epidiolex, is only available through the study, according to the state Health Department. Continued at blog.timesunion.com/healthcare/marijuana-studies-for-children-with-epilepsy-to-begin-in-n-y/4110/ .
|
|